gammagraphy

(redirected from Breast-Specific Gamma Imaging)
Also found in: Medical, Acronyms.
Related to Breast-Specific Gamma Imaging: gammagram
Translations
gammagraphie

gammagraphy

n. gammagrafía, registro de rayos gamma después de la administración de isótopos radioactivos.
English-Spanish Medical Dictionary © Farlex 2012
Mentioned in ?
References in periodicals archive ?
In the study, the LumaGEM MBI System established its clinical importance by demonstrating a reduction in radiation dose from 20mCi3 to 8mCi, a dose reduction not achievable with older-generation scintillating gamma cameras, known as scintimammography or breast-specific gamma imaging systems4.
Screening has become more complicated with introduction of positron emission mammography (PEM) and breast-specific gamma imaging (BSGI) which involves much higher radiation levels and injection of radio-opaque dye which increase the risk of cancer up to 20 to 30 times compared with traditional X-rays (Morales, 2013).
Brem points out that breast-specific gamma imaging (BSGI), can be used as a supplemental test to mammography, offers comparable sensitivity to MRI, and is far less expensive.
Breast-Specific Gamma Imaging (an imaging technique that is a follow-up to mammography that can see lesions independent of tissue density and discover early stage cancer) and Magnetic Resonance Imaging (which creates detailed pictures of the breast and gives physicians information about the location and nature of the cancerous or non-cancerous mass).
Radionuclide imaging of the breast covers a number of different forms of nuclear medicine scans, from positron emission mammography (PEM) to breast-specific gamma imaging to molecular breast imaging (MBI).
In addition to mammography and positron emission mammography (PEM), the practice offers full-service, multi-modality imaging including 1.5T and 3T MRI; FONAR, multi-positional, open and upright MRI; breast MRI; breast-specific gamma imaging; ultrasound; 64-slice CT: PET/CT; nuclear medicine; bone densitometry; fluoroscopy/X-ray; and interventional pain management and therapeutic injections.
Summary: Dilon Diagnostics, the leader in molecular breast imaging (MBI) also known as Breast-Specific Gamma Imaging (BSGI) and Philips (NYSE:PHG) (NYSE:AEX:) (NYSE:PHI) , today announce that they have entered into a distribution agreement.